<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Skin and Venereal Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Skin and Venereal Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский журнал кожных и венерических болезней</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1560-9588</issn><issn publication-format="electronic">2412-9097</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">62377</article-id><article-id pub-id-type="doi">10.17816/dv62377</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL PICTURE, DIAGNOSIS, AND THERAPY OF DERMATOSES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИКА, ДИАГНОСТИКА И ЛЕЧЕНИЕ ДЕРМАТОЗОВ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lyell´s syndrome provoked by external drug use</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром Лайелла, спровоцированный наружным применением лекарственных средств</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4845-8753</contrib-id><contrib-id contrib-id-type="spin">2796-9975</contrib-id><name-alternatives><name xml:lang="en"><surname>Krivosheev</surname><given-names>Alexandr B.</given-names></name><name xml:lang="ru"><surname>Кривошеев</surname><given-names>Александр Борисович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>krivosheev-ab@narod.ru</email><uri>http://ngmu.ru</uri><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4725-7308</contrib-id><name-alternatives><name xml:lang="en"><surname>Ermachenko</surname><given-names>Tamara V.</given-names></name><name xml:lang="ru"><surname>Ермаченко</surname><given-names>Тамара Викторовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><email>ermat@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5501-0543</contrib-id><name-alternatives><name xml:lang="en"><surname>Khavin</surname><given-names>Pavel P.</given-names></name><name xml:lang="ru"><surname>Хавин</surname><given-names>Павел Петрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>terapia@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3575-4983</contrib-id><name-alternatives><name xml:lang="en"><surname>Krivosheeva</surname><given-names>Inga A.</given-names></name><name xml:lang="ru"><surname>Кривошеева</surname><given-names>Инга Анатольевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>terapia@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1773-7140</contrib-id><name-alternatives><name xml:lang="en"><surname>Morozov</surname><given-names>Dmitry V.</given-names></name><name xml:lang="ru"><surname>Морозов</surname><given-names>Дмитрий Вильевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н.</p></bio><email>mdvil07@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Novosibirsk State Medical University</institution></aff><aff><institution xml:lang="ru">Новосибирский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">City Clinical Hospital No 1</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 1</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">City Clnical Hospital No 1</institution></aff><aff><institution xml:lang="ru">Городская клиническая больница № 1</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2021-02-15" publication-format="electronic"><day>15</day><month>02</month><year>2021</year></pub-date><volume>24</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>25</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2021-03-01"><day>01</day><month>03</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-03-17"><day>17</day><month>03</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, ООО "Эко-Вектор"</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">ООО "Эко-Вектор"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-08-01"/></permissions><self-uri xlink:href="https://rjsvd.com/1560-9588/article/view/62377">https://rjsvd.com/1560-9588/article/view/62377</self-uri><abstract xml:lang="en"><p>Lyell´s syndrome is rare. Up to 10 cases are registered per million population per year. The mortality rate for Lyell’s syndrome is 5–12%.</p> <p>Two patients were observed aged, respectively, 38 years and 72 years with Lyell’s syndrome. The disease manifested itself against the background of local application of drugs. In one case ― Doloben’s gel as an analgesic at the site of a bruise of the right hand. In another case, a 20% solution of chlorohxidin biogluconate as a mouth rinse for stomatitis. The first symptoms of the disease occurred locally at the site of application of these medicines. In the first case, the skin of the right hand, in the second ― the mucous membrane of the mouth. The outcome of the disease depended on early diagnosis, urgent hospitalization in a specialized department, from the area of skin lesions, the appointment of adequate therapy.</p> <p>Lyell’s syndrome can occur at any age, and the risk of developing the disease increases in those over the age of 40. In the elderly, SL in terms of the first symptoms and rate of disease progression, the nature of skin and mucous membrane lesions does not have any fundamental differences with those in younger patients. The distinctive features and risk factors of Lyell’s syndrome in the elderly include, firstly, its occurrence against the background of the already formed comorbid age-related pathology of internal organs, secondly, the concomitant age-related pathology during the development of an acute toxic-allergic reaction is decompensated, a multiorgan failure is formed, which is the cause of more severe Lyell’s syndrome and higher mortality. In young people, a comorbid viral infection can be considered a risk factor, especially the combination of HIV-infection and chronic hepatitis C.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром Лайелла встречается редко: регистрируется до 10 случаев на 1 млн населения в год. Смертность при синдроме Лайелла составляет 5–12%.</p> <p>Наблюдали двух больных синдромом Лайелла в возрасте 38 и 72 лет. Заболевание манифестировало на фоне местного применения лекарственных препаратов: в одном случае это был гель «Долобена» в качестве анальгезирующего средства в месте ушиба правой кисти, в другом ― 20% раствор хлоргексидина биоглюконата для полоскания ротовой полости в связи со стоматитом. Первые симптомы заболевания возникли локально в месте применения этих лекарственных средств ― на коже правой кисти– и слизистой оболочке ротовой полости соответственно. Исход заболевания зависел от ранней диагностики, срочной госпитализации в специализированное отделение, площади поражения кожи, назначения адекватной терапии. У лиц пожилого возраста в сравнении с более молодыми пациентами синдром Лайелла по первым симптомам и темпу прогрессирования болезни, характеру поражения кожи и слизистых оболочек не имеет принципиальных различий.</p> <p>Синдром Лайелла может возникать в любом возрасте, риск развития заболевания возрастает у лиц старше 40 лет. К отличительным особенностям и факторам риска синдрома Лайелла у пожилых людей относят, во-первых, его возникновение на фоне уже сформировавшейся коморбидной возрастной патологии внутренних органов, во-вторых, сопутствующая возрастная патология при развитии токсико-аллергической реакции декомпенсируется, и формируется полиорганная недостаточность, что является причиной тяжёлого течения синдрома Лайелла и высокой смертности. У лиц молодого возраста к факторам риска можно отнести коморбидную вирусную инфекцию, особенно сочетание вируса иммунодефицита и хронического гепатита C.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Lyell’s syndrome</kwd><kwd>comorbid pathology of internal organs</kwd><kwd>HIV-infection</kwd><kwd>chronic hepatitis C</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром Лайелла</kwd><kwd>коморбидная патология внутренних органов</kwd><kwd>ВИЧ-инфекция</kwd><kwd>хронический гепатит С</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol. 1956;68(11):355–361. doi: 10.1111/j.1365-2133.1956.tb12766.x</mixed-citation><mixed-citation xml:lang="ru">Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin // Br J Dermatol. 1956. Vol. 68, N 11. Р. 355–361. doi: 10.1111/j.1365-2133.1956.tb12766.x</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Krivosheev BN, Mezhberg LB, Ronzhina ZG, Kovalevskaya MG. Toxic epidermal necrolysis ― Lyell’s syndrome. Clinical Medicine. Russian Journal. 1972;(6):126–130. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Кривошеев Б.Н., Межберг Л.Б., Ронжина З.Г., Ковалевская М.Г. Токсический эпидермальный некролиз ― синдром Лайла // Клиническая медицина. 1972. № 6. С. 126–30.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Butov YuS, Skripkin YuK, Ivanov OL, eds. Dermatovenereology. National leadership. Moscow: GEOTAR-Media; 2013. 1021 р. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Бутов Ю.С., Скрипкин Ю.К., Иванов О.Л., ред. Дерматовенерология. Национальное руководство. Москва : ГЭОТАР-Медиа, 2013. 1021 с.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Khokhlova ZA, Gileva RA, Konyakhina IG, Tishkina AP. Lyell’s syndrome. Practical case. Rus Arch Inter Med. 2018;8(3):231–236. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Хохлова З.А., Гилева Р.А., Коняхина И.Г., Тишкина А.П. Синдром Лайелла. Случай из практики // Архивъ внутренней медицины. 2018. Т. 8, № 3. С. 231–236.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Fitzpatrick T, Johnson R, Wolfe K, et al. Dermatology according to Thomas Fitzpatrick: Atlas-handbook. Trans. from English. E.A. Okisheva, A.V. Snegovskaya, E.R. Timofeeva. 2nd Russian ed. Moscow: Praktika; 2007. 1248 p.</mixed-citation><mixed-citation xml:lang="ru">Фицпатрик Т., Джонсон Р., Вульф К. и др. Дерматология по Томасу Фицпатрику: Атлас-справочник. Пер. с англ. Е.А. Окишевой, А.В. Снеговской, Е.Р. Тимофеевой. 2-е рус. изд. Москва : Практика, 2007. 1248 с.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Krivosheev BN, Kuimov AD, Krivosheev AB, Morozov DV. Lyell’s syndrome in the elderly. Russian Journal of Skin and Venereal Diseases. 2009;12(6):10–18. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Кривошеев Б.Н., Куимов А.Д., Кривошеев А.Б., Морозов Д.В. Синдром Лайелла у пожилых людей // Российский журнал кожных и венерических болезней. 2009. Т. 12, № 6. С. 10–18.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Kudo T, Nakajima K, Shiga T, et al. Successful treatment for toxic epidermal necrolysis / drug-induced hypersensitivity syndrome overlap with corticosteroids, intravenous immunoglobulins and plasma exchange. J Clin Exp Dermatol Res. 2014;5(3):216–218. doi: 10.1016/j.jds.2015.03.008</mixed-citation><mixed-citation xml:lang="ru">Kudo T., Nakajima K., Shiga T., et al. Successful treatment for toxic epidermal necrolysis /drug-induced hypersensitivity syndrome overlap with corticosteroids, intravenous immunoglobulins and plasma exchange // J Clin Exp Dermatol Res. 2014. Vol. 5, N 3. Р. 216–218. doi: 10.1016/j.jds.2015.03.008</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Lyell A. A review of toxic epidermal necrolysis in Britain. Br J Dermatol. 1967;79(12):662–671. doi: 10.1111/j.1365-2133.1967.tb11434.x</mixed-citation><mixed-citation xml:lang="ru">Lyell A. A review of toxic epidermal necrolysis in Britain // Br J Dermatol. 1967. Vol. 79, N 12. Р. 662–671. doi: 10.1111/j.1365-2133.1967.tb11434.x</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Krivosheev BN, Kuimov AD, Krivosheev AB, et al. Lyell’s sindrome provoked by biologically active food additive. Russian Journal of Skin and Venereal Diseases. 2007;10(3):48–51. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Кривошеев Б.Н., Куимов А.Д., Кривошеев А.Б. и др. Синдром Лайелла, спровоцированный биологически активной добавкой к пище // Российский журнал кожных и венерических болезней. 2007. Т. 10, № 3. С. 48–51.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Koudelka EN, Shakhmatov DM, Sobolev AF, et al. Toxic epidermal necrolysis (Lyell’s Syndrome). Russian Journal of Infektology. 2017;9(4):144–152. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Куделка Е.Н., Шахматов Д.М., Соболев А.Ф. и др. Токсический эпидермальный некролиз (синдром Лайелла) // Журнал инфектологии. 2017. Т. 9, № 4. С. 144–152.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol. 1979;100(1):69–86. doi: 10.1111/j.1365-2133.1979.tb03571.x</mixed-citation><mixed-citation xml:lang="ru">Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal // Br J Dermatol. 1979. Vol. 100, N 1. Р. 69–86. doi: 10.1111/j.1365-2133.1979.tb03571.x</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Es H, Arslan MN, Yagmur G, Karayel FA. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case. Turkish J Foren Med. 2015;29(2):118–123. doi: 10.5505/adlitip.2015.28190</mixed-citation><mixed-citation xml:lang="ru">Es H., Arslan M.N., Yagmur G., Karayel F.A. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case // Turkish J Foren Med. 2015. Vol. 29, N 2. Р. 118–123. doi: 10.5505/adlitip.2015.28190</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Krivosheev BN, Tonsheva LN, Samoteykina YuM, Shakhmatov DA. Of a complication at external use of Furacilin. Soviet Medicine. Russian Journal. 1990;(12):87–90. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Кривошеев А.Б., Тоньшева Л.Н., Самотейкина Ю.М., Шахматов Д.А. Осложнения при наружном применении фурацилина // Советская медицина. 1990. № 12. С. 87–90.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Homich FA, Podobed YuI. Ostry toxic epidermalny nekroliz. Health Care of Belarus. 1968;(2):87. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Хомич Ф.А., Подобед Ю.И. Острый токсический эпидермальный некролиз // Здравоохранение Белоруссии. 1968. № 2. С. 87.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Zaslavsky DV, Gorlanov IA, Samtsov AV, Khairutdinov VR. Federal clinical recommendation on patients with Steven-Johnson syndrome / Toxic epidermal necrolysis. Moscow: Russian Dermatovenerologists and Cosmetologists Society; 2015. (In Russ). Available from:</mixed-citation><mixed-citation xml:lang="ru">Заславский Д.В., Горланов И.А., Самцов А.В., Хайрутдинов В.Р. Федеральные клинические рекомендации по ведению больных синдромом Стивенса-Джонсона / токсическим эпидермальным некролизом. Москва : Российское общество дерматовенерологов и косметологов, 2015. Режим доступа: https://www.ismos.ru/guidelines/doc/sindrom_stivenca-dzhonsona.pdf. Дата обращения: 26.12.2020.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">https://www.ismos.ru/guidelines/doc/sindrom_stivenca-dzhonsona.pdf</mixed-citation><mixed-citation xml:lang="ru">Halevy S., Ghislain P.D., Mockenhaupt M., et al.; EuroSCAR Study Group. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel // J Am Acad Dermatol. 2008. Vol. 58, N 1. Р. 25–32. doi: 10.1016/j.jaad.2007.08.036</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Halevy S, Ghislain PD, Mockenhaupt M, et al.; EuroSCAR Study Group. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. J Am Acad Dermatol. 2008;58(1):25–32. doi: 10.1016/j.jaad.2007.08.036</mixed-citation><mixed-citation xml:lang="ru">Mockenhaupt M., Viboud C., Dunant A., et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: Assessment of medication risk with emphasis on recently marketed druds. The EuroSCAR-study // J Invest Dermatol. 2008. Vol. 128, N 1. Р. 35–44. doi: 10.1038/sj.jid.5701033</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risk with emphasis on recently marketed druds. The EuroSCAR-study. J Invest Dermatol. 2008;128(1):35–44. doi: 10.1038/sj.jid.5701033</mixed-citation><mixed-citation xml:lang="ru">Тезяева С.А., Млинник Р.А., Дегтярева С.Ф. и др. Синдром Лайелла как редкое осложнение медикаментозной терапии (клинические случаи) // Медиаль. 2015. Т. 2, № 16. С. 42–45.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Tezyaeva SA, Mlinnik RA, Degtyareva SF, et al. Lyell’s Syndrome as a rare complication of drug therapy (clinical cases). Medial. 2015;2(16):42–45. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Некролиз токсический эпидермальный (синдром Стивенса-Джонсона). Клинические рекомендации. Москва, 2016. Режим доступа: https://medi.ru/klinicheskie-rekomendatsii/nekroliz-toksicheskij-epidermalnyj-sindrom-stivensa-dzhonsona_14105/. Дата обращения: 26.12.2020.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Toxic epidermal necrolysis (Stevens-Johnson syndrome). Clinical recommendation. Moscow; 2016. (In Russ). Available from: https://medi.ru/klinicheskie-rekomendatsii/nekroliz-toksicheskij-epidermalnyj-sindrom-stivensa-dzhonsona_14105/</mixed-citation><mixed-citation xml:lang="ru">Auquier-Dunant A., Mockenhaupt M., Naldin L., et al.; SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlation between clinical patterns and causes of erythema multiforme major, Stevens Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study // Arch Dermatol. 2002. Vol. 138, N 8. Р. 1019–1024. doi: 10.1001/archderm.138.8.1019</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Auquier-Dunant A, Mockenhaupt M, Naldin L, et al.; SCAR Study Group. Severe Cutaneous Adverse Reactions. Correlation between clinical patterns and causes of erythema multiforme major, Stevens Johnson syndrome and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138(8):1019–1024. doi: 10.1001/archderm.138.8.1019</mixed-citation><mixed-citation xml:lang="ru">Conroy R.M., Pyorala K., Fitzgerald A.P., et al.; SCORE project group. Estimation of ten-year risk of total cardiovascular disease in Europe: the SCORE project // Eur Heart J. 2003. Vol. 24, N 11. Р. 987–1003. doi: 10.1016/s0195-668x(03)00114-3</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Conroy RM, Pyorala K, Fitzgerald AP, et al.; SCORE project group. Estimation of ten-year risk of total cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24(11):987–1003. doi: 10.1016/s0195-668x(03)00114-3</mixed-citation><mixed-citation xml:lang="ru">Huseyin E., Murat N.A., Gulhan Y. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case // J For Med Gut. 2014. Vol. 29, N 2. Р. 118–123. doi: 10.5505/adlitip.2015.28190</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><mixed-citation>Huseyin E, Murat NA, Gulhan Y. Toxic epidermal necrolysis like bullous skin reaction: an autopsy case. J For Med Gut. 2014;29(2):118–123. doi: 10.5505/adlitip.2015.28190</mixed-citation></ref></ref-list></back></article>
